Skip to content

Biofortuna vs LEX Diagnostics

Biofortuna logo

Biofortuna

Flexible and transparent support for life science innovators. Assay development, manufacturing and laboratory services

33 employees · est. 2008 · United Kingdom

VS
LEX Diagnostics logo

LEX Diagnostics

Molecular diagnostics for primary care

41 employees · est. 2020 · United Kingdom

Biofortuna is the older company (2008 vs 2020).

Side-by-Side Comparison

Biofortuna LEX Diagnostics
Founded
2008 older 2020
Headquarters
United Kingdom United Kingdom
Employees
33 41
Industry
Biotechnology, Health Care Biotechnology, Care Economy, Health Care
Funding Stage
Venture round Not tracked yet
Total Funding
$4.99M Not tracked yet
Funding Rounds
3 Not tracked yet
Taxonomy
In Vitro DiagnosticsPoint Of Care TestingMolecular DiagnosticsLife SciencesContract ManufacturingAssay Development +9 Molecular DiagnosticsPCRPoint Of Care DiagnosticsViral PathogensPrimary CareNasal Samples +8
Website
biofortuna.com lexdiagnostics.com
Biofortuna logo

About Biofortuna

Biofortuna is a biotechnology company headquartered in the United Kingdom. Founded in 2008, the company specializes in development and contract manufacturing for the global in vitro diagnostic and point of care testing sectors. With a strong focus on forming unique partnerships with innovative heal...

LEX Diagnostics logo

About LEX Diagnostics

LEX Diagnostics is a molecular diagnostics startup founded in 2020 in the United Kingdom. The company's focus lies in developing cutting-edge products to revolutionize patient care by providing clinical insights within minutes, particularly in primary care settings. Their goal to deliver a high-spee...

Also comparing in this category

Comparing more than these two?

Get Biofortuna, LEX Diagnostics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Biofortuna compare?

A PDF of Biofortuna and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Biofortuna was founded in 2008, based in United Kingdom, with 33 employees. Biofortuna is a biotechnology company headquartered in the United Kingdom. Founded in 2008, the company specializes in development and contract manufacturing for the global in vitro diagnostic and poi. LEX Diagnostics was founded in 2020, based in United Kingdom, with 41 employees. LEX Diagnostics is a molecular diagnostics startup founded in 2020 in the United Kingdom. The company's focus lies in developing cutting-edge products to revolutionize patient care by providing clinic.
Biofortuna has raised $4.99M and LEX Diagnostics no disclosed funding. Latest stage: Biofortuna Venture round.
Both work in Biotechnology and Health Care and list molecular diagnostics, life sciences and pcr among their focus areas.

Compare Biofortuna with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Biofortuna on 12 Sep 2024, and LEX Diagnostics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout